Webinar: Engaging Your Delegates Towards Professional Excellence
You have filled in a form on the universalmedica.com website to receive access to the replay of the following webinar: “Engaging Your Delegates Towards Professional Excellence”. Click on the link below to view it: REPLAY If you have any questions or would like to have a brief discussion on this subject, please do not hesitate […]
Meeting point at DIA Europe 2019 – 20 and 21 November – Lisbon Portugal
In march 2019, Universal Medica Group and EVERSANA have entered into a partnership to provide medical information and pharmacovigilance services throughout Europe, Asia and North, Central and South America. This strategic collaboration meets the evolving needs of Global clients. As a single, integrated service partner EVERSANA and Universal Medica Group deliver programs with the infrastructure, […]
DIA Europe 2018 – 17 & 19 Avril, Bazel Switzerland
Universal Medica your partner in medical communication will be present at this year’s DIA conference in Basel, Switzerland. We would like to share with you our vision of the evolution of Medical Affairs and listen to your current and future needs in this evolving environment. The future of drug safety management is changing and becoming a crucial […]
Interview – Emmanuelle B. : Pharmacovigilance Manager
Presentation I am a pharmacist (PharmD) and I have a University thesis in PharmacoEpidemiology (PhD). Afterwards, I worked during 15 years as a practitioner in the Regional Center of Pharmacovigilance (CRPV) of Toulouse before joining Universal Medica as Pharmacovigilance Manager (PV). During these 15 years, I carried out numerous appraisals for the ANSM, in particular […]
The early bird of Innovation Days 2015 is coming to an end!
Only a few days left to take advantage of the preferential rate for registration for Innovation Days 2015, which will be held on 5 and 6 October at the Cité Universitaire de Paris. Strategic alliances, open innovation and e-health are on the agenda this year, with interactive conferences led by experts. This is also the […]
Meet Universal Medica at DIA Euromeeting 2015 – April 13, 14 &15 2015
This year, Universal Medica is attending to the 27 th DIA Annual Euromeeting on 13 to 15 april 2015. What is DIA 2015? DIA Euromeeting is the opportunity to reach the full range of medicines development professionnals. From pharmaceuticals and biotech industry to CROs, regulators froms EMA, FDA and euopean countries national regulatory agencies and […]
Less than 3 weeks before the opening of the call for proposal!
Innovation Prize: What? For the 7th consecutive year, Universal Biotech launches the Innovation Prize rewarding young starts-up and academic research groups in the field of Life Sciences. With the support of public organizations, pharmaceutical laboratories and biotechnology companies, the Innovation Prize aims to promote innovation in the healthcare industry. You will be able to submit […]
Universal Medica Group wishes you a very happy 2015!
The entire Universal Medica team wishes you a very happy new year, full of joy and happiness. 2014 was a year full of challenges, we look forward to cooperating with you again to face the ones 2015 has in store! Click on the cherry to find out more about our new activities
The ANSM is suspending 25 generic drugs marketed in France.
The ANSM is initiating a suspension procedure, as of December 18, of 25 drugs marketed in France. An inspection by the ANSM of a site of the company GVK Bio, which carries out clinical trials including bioequivalence trials in India, has revealed irregularities in documents associated with these trials on which the MA (marketing authorisation) […]
2014 Innovation Award winner signs $25 million development deal with Pfizer
Dear all, We are pleased to announce that one of the 5 finalists of the 2014 Innovation Prize has entered into a $25 million development agreement with pharmaceutical company Pfizer. In fact, Belgian company iTeos Therapeutics, led by Michel Detheux, is developing drug candidates that target Indoleamine-2,3-Dioxygenase (IDO1) and Tryptophan-2,3-Dioxygenase (TDO2). This news highlights the […]
